West Pharmaceutical Services, Inc. (WST) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $360.74 -1.6%
EPS Growth %: +11.7%
Financial Fact:
Equity in net income of affiliated companies: 2.7M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +11.7%
Financial Fact:
Equity in net income of affiliated companies: 2.7M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q2 EPS of $0.79, $0.10 better than the analyst estimate of $0.69. Revenue for the quarter came in at $324.8 million versus the consensus estimate of $321.5 million.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Premarket movers: Xenon sinks on trial pause, Netflix hit by downgrade
- Can global equities keep rising? UBS sees these factors driving upside
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
